People | Page 492 of 525 | SpiritIndia.com

Restless Legs Syndrome :: Requip – ropinirole for Restless Legs Syndrome

The Food and Drug Administration has approved Requip (ropinirole) to treat moderate to severe Restless Legs Syndrome (RLS). The drug was first approved for Parkinson?s disease in 1997.

Immune System :: How disease bacterium survives inside immune system cell

New research on a bacterium that can survive encounters with specific immune system cells has strengthened scientists? belief that these plentiful white blood cells, known as neutrophils, dictate whether our immune system will permit or prevent bacterial infections. A paper describing the research was released today online in The Journal of Immunology. Frank R. DeLeo, Ph.D., of Rocky Mountain Laboratories (RML), part of the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health, directed the work at RML, in Hamilton, MT, in collaboration with lead author Dori L. Borjesson, D.V.M., Ph.D., of the University of Minnesota in St. Paul.

Vitamin D :: Boost Vitamin D intake through diet and supplements

Based on data reviewed by a consensus conference convened by the American Academy of Dermatology Association (Academy) to examine the relationship between sunlight, tanning booths and vitamin D, renowned medical experts agreed that increasing exposure to either natural or artificial ultraviolet (UV) light should not be recommended as a supplemental source of vitamin D.

Exercise :: Regular physical activity and exercise brings health

A new study from Karolinska Institutet in Stockholm shows that hundreds of genes in the thigh muscle are activated in regular cycle training. The study also reveals that great differences in training response may be due to the ability in some people to activate their genes much more forcefully. The study is published May 2 in FASEB Journal.

Homeopathy :: The Ground Reality – Experiences in a Rural Area

The Fundamental Principles of Homoeopathy are well known to all Homoeopathic Physicians. But, as they say, it becomes a difficult task to stick to them when you are posted in a rural backdrop or when posted in a dispensary and lots of patients have to be seen- and you can’t devote more than 3-4 minutes on every patient. So, many people told me, but when I also got posted in this rural dispensary some of my friends said let us see how you can follow the path of mono and mini medicines.

Gangrene :: A chronic disease – gangrene

Gangrene is the term used to describe the decay or death of an organ or tissue caused by a lack of blood supply. It is a complication resulting from infectious or inflammatory processes, injury, or degenerative changes associated with chronic diseases, such as diabetes mellitus.

Drug Abuse :: Alprazolam, Xanax in insomnia and daytime anxiety

Drugs marketed in the United States that affect central nervous system function, Alprazolam/Xanax is among the most widely prescribed medications. Xanax is a longer duration Benzodiazepine which is prescribed to treat insomnia in patients with daytime anxiety or patients with Generalized Anxiety Disorder (GAD) and Panic Disorders.

Weight loss :: Mental approach to weight loss – obesity

The one thought that crosses the minds of millions everyday is – How wonderful would life become if I would be slim? – I am not stressing on the belief that fat people do not or cannot lead good lives; it is about their motivation behind the plan to lose weight. The question arises how they discover themselves?

Obesity :: Obesity common among the affluent, rich and wealthy

The poor are most likely to be fat, but the more affluent are closing the gap. Obesity is growing fastest among Americans who make more than $60,000 a year, researchers reported.

Depression :: Requests for medications boost prescribing for depression

Researchers funded by the National Institute of Mental Health (NIMH), part of the National Institutes of Health, have found that requests from patients for medications have a “profound effect” on physicians prescribing for major depression and adjustment disorder. These findings indicate that direct-to-consumer (DTC) marketing of prescription medications for depression may exert significant influence on treatment decisions.